Joe Sardano, CEO of Sensus Healthcare (NASDAQ: SRTS), talks to our hosts about non-invasive skin cancer treatments, recent Medicare reimbursement changes, growing demand for alternatives to surgery, and the company’s plans for future growth and innovation.
February 7, 2023
